Sunscreen Rule Will Cost Four Times FDA’s Prediction, Industry Tells OMB
This article was originally published in The Tan Sheet
Executive Summary
FDA's low-ball estimate of the cost to industry from the final OTC sunscreen monograph – a quarter of the amount manufacturers anticipate – relieved the agency from having to submit a full account of its rulemaking to the Office of Management and Budget, Energizer Holdings suggests.